Filters

MAGEA9, ID (Melanoma-associated Antigen 9, MAGE-9 Antigen, Cancer/Testis Antigen 1.9, CT1.9, MAGE9, MAGEA9A) Antibody

MAGEA9, ID (Melanoma-associated Antigen 9, MAGE-9 Antigen, Cancer/Testis Antigen 1.9, CT1.9, MAGE9, MAGEA9A) Antibody size: 200ul 603

Price 603
Size 200ul
Alternative name1 CT1, Cancer/Testis Antigen 1, ID (Melanoma-associated Antigen 9, MAGE-9 Antigen, MAGE9, MAGEA9A), 9, 9, Anti-MAGEA9
Alternative name2 CT1, Cancer/Testis Antigen 1, ID (Melanoma-associated Antigen 9, MAGE-9 Antigen, MAGE9, MAGEA9A), 9, 9, MAGEA9
Alternative name3 CT1, Cancer/Testis Antigen 1, ID (Melanoma-associated Antigen 9, MAGE-9 Antigen, MAGE9, MAGEA9A), 9, 9, MAGEA9
Alternative name4MAGEA9
Alternative name5 CT1, Cancer/Testis Antigen 1, ID (Melanoma-associated Antigen 9, MAGE-9 Antigen, MAGE9, MAGEA9A), 9, 9, Anti -MAGEA9
Other names 9B, CT1, CT1, Cancer/testis antigen 1, MAGE-9 antigen, MAGE-9 antigen, Melanoma-associated antigen 9, OTTHUMP00000216441, cancer/testis antigen 1, melanoma antigen family A, melanoma-associated antigen 9, 9, 9, 9, 9, melanoma-associated antigen 9
Gene nameN/A
Gene name synonimsN/A
Other gene names MAGE9, MAGEA9, MAGEA9, MAGEA9A, MAGEA9B
CategoryAntibodies
ClonalityPolyclonal
Immunoglobulin isotypeIgG
ClonePolyclonal antibody
Host organism Source: Human, Host: Rabbit
Species reactivityHuman
Specificity and cross-reactivityRecognizes human MAGEA9
Purification methodAffinity Purified by Protein G affinity chromatography
Form/Appearance 0, 09% sodium azide, Supplied as a liquid in PBS
ConcentrationN/A
Storage and shipping Aliquot to avoid repeated freezing and thawing, Aliquots are stable for at least 12 months, For maximum recovery of product, For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage
Tested for: Immunohistochemistry (IHC), Western Blot (WB), ELISA (EL/EIA)
Description Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24°
Gene target CT1, ID (Melanoma-associated 9, MAGE-9 Cancer/Testis 1, MAGE9, MAGEA9A), 9, 9, MAGEA9
Short name CT1, Cancer/Testis Antigen 1, ID (Melanoma-associated Antigen 9, MAGE-9 Antigen, MAGE9, MAGEA9A) Antibody, 9, 9, MAGEA9
Technique antibodies against human proteins, antibodies for, Antibody
Alternative name CT1, Cancer/Testis protein 1, ID (Melanoma-associated protein 9, MAGE-9 protein, MAGE9, MAGEA9A) (Antibody to), 9, 9, MAGEA9
Alternative techniqueantibodies
Identity 6807
Gene MAGEA9
Long gene name MAGE family member A9
Synonyms gene MAGE9
Synonyms gene name melanoma antigen family A9
Synonyms MGC8421 CT1, 9
Synonyms name MAGE-9 antigen melanoma-associated antigen 9 cancer/testis antigen family 1, member 9
Locus Xq28
Discovery year 1994-04-04
Entrez gene record 4108
Pubmed identfication 8575766
RefSeq identity NM_005365
Classification MAGE family
Havana BLAST/BLAT OTTHUMG00000022621

Subscribe to our Newsletter